CTOs on the Move

Colusa Regional Medical Center

www.colusamedicalcenter.org

 
Colusa Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Colusa Regional Medical Center is based in Colusa, CA. You can find more information on Colusa Regional Medical Center at www.colusamedicalcenter.org
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Carevive Systems

Carevive Systems, founded in 2013, is an oncology-focused health technology company focused on understanding and improving the cancer patient experience.

AlwaysCare Benefits

AlwaysCare Benefits is a Baton Rouge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delta Regional Medical Center

Delta Regional Medical Center has been committed to serving the citizens of Washington County and the outlying areas since our founding in the 1950s. Over time we have grown and progressed into a state-of-the-art hospital with a number of specialty

Lawnwood Regional Medical Center and Heart Institute

Lawnwood Regional Medical Center and Heart Institute is a Fort Pierce, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioSig Technologies

BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.